Empagliflozin treatment does not affect the hypertensive response to Ang II administration to rats but decreases oxidative stress in the arterial wall, and endothelial and cardiac dysfunction
Authors: C Bruckert, L Remila, K Matsushita, C Auger, U Houngue, A Chaker, S Park, P Algara-Suarez, E Belcastro, L Jesel, P Ohlmann, O Morel, V Schini-Kerth